4 April 2008
Phorm advertising – ICO statement
A spokesperson for the Information Commissioner’s Office said:
“The ICO has received a number of queries concerning the recent announcement by
Phorm that 3 major UK Internet Service Providers have agreed to allow them to use
technology, developed by Phorm, to present adverts to their customers based on the
nature of the websites they visit.
“Understandably, this has provoked considerable public concern. We have had detailed
discussions with Phorm. They assure us that their system does not allow the retention of
individual profiles of sites visited and adverts presented, and that they hold no personally
identifiable information on web users. Indeed, Phorm assert that their system has been
designed specifically to allow the appropriate targeting of adverts whilst rigorously
protecting the privacy of web users. They clearly recognise the need to address the
concerns raised by a number of individuals and organisations including the Open Rights
Group. We welcome the efforts they are making to engage with sceptical technical experts
and believe that it is only by allowing their technology to be subject to detailed scrutiny by
independent technical experts that they will be able to prove their assertions regarding
privacy. The ICO strongly supports the use of technology in ways which enhance rather
than intrude upon privacy, and plans to produce a report on “Privacy by Design” later this
year.
“We understand that the technology is not yet in use and that BT intends to run a trial
involving around 10,000 broadband users later this month. We have spoken to BT about
this trial and they have made clear that unless customers positively opt in to the trial their
web browsing will not be monitored in order to deliver adverts. BT has also stated that the
system does not store personally identifiable information, URLs, IP addresses or retain
browsing histories and that search information is deleted almost immediately, and is not
retrievable.
“We will continue to maintain close contact with Phorm and BT throughout the trial. Clearly
the trial should reveal whether this is a service that web users want, whether it is privacy
friendly and that users are comfortable with the privacy safeguards put in place by Phorm.”
For all media enquires, please contact the ICO press office on 0207 025 7580.
For all general enquires, please contact the ICO customer service team on 08456
306060.